DUBLIN–(BUSINESS WIRE)–The “Compounding Pharmacies Market, by Product Type, by Therapeutic Area, by Application, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.
Compounded medications are prepared by compounding pharmacies to meet the needs of unique patients whose conditions cannot be treated by commercially accessible medications. The process of combining, blending, or changing substances to make a treatment specific to the requirements of a particular patient is known as drug compounding. Combining two or more medications is referred to as compounding.
It may be essential to compound a drug for a patient who cannot be treated with an FDA-approved drug, such as one who has a dye allergy and needs a medication to be made without it, or a patient who is elderly or a child who is unable to swallow a tablet or capsule and needs a medication in a liquid dosage form. Hospitals, clinics, and other healthcare facilities’ doctors occasionally provide patients compounded pharmaceuticals when an FDA-approved drug is not medically required to treat them.
Sometimes, when an Food and Drug Administration (FDA)-approved medication is not medically necessary to treat a patient, doctors in hospitals, clinics, and other healthcare institutions will give them compounded drugs. A compounding pharmacy is a specific type of pharmacy. They make medications for people who have certain medication needs or requirements.
Market Dynamics
Increasing geriatric population is expected to drive market growth over the forecast period. For instance, according to data published in February 2022, on International Association for the Study of Pain, which is an international learned society promoting research, education, and policies for the understanding, prevention, and treatment of pain, stated that, in 2021, about 50 million elder patients were suffering from chronic pain globally.
Key features of the study:
This report provides in-depth analysis of the global compounding pharmacies market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global compounding pharmacies market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global compounding pharmacies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global compounding pharmacies market
Detailed Segmentation:
Global Compounding Pharmacies Market, By Product Type:
Oral
Capsule
Tablets
Mixtures
Lollipops
Lozenges
Topical
Gels
Ointments
Cream
Lotions
Rectal
Parenteral
Nasal
Ophthalmic
Mouthwashes
Global Compounding Pharmacies Market, By Therapeutic Area:
Pain Management
Hormone Replacement Therapy (HRT)
Dermatology
Specialty Drugs
Global Compounding Pharmacies Market, By Application:
Pediatric
Adults
Geriatric
Veterinary
Global Compounding Pharmacies Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Compounding Pharmacies Market- Impact of Coronavirus (Covid-19) Pandemic
5. Global Compounding Pharmacies Market, By Product Type, 2017 – 2030, (US$ Million)
6. Global Compounding Pharmacies Market, By Therapeutic Area, 2017 – 2030, (US$ Million)
7. Global Compounding Pharmacies Market, By Application, 2017 – 2030, (US$ Million)
8. Global Compounding Pharmacies Market, By Region, 2017 – 2030, (US$ Million)
9. Competitive Landscape
10. Section
Companies Mentioned
Avella Specialty Pharmacy
Central Admixture Pharmacy Services
Fagron
Fresenius Kabi AG
PharMEDium Services
Institutional Pharmacy Solutions
Cantrell Drug Company
Triangle Compounding Pharmacies
Lorraine’s Pharmacy
Rx3 Compounding Pharmacy
B Braun Melsungen AG
Clinigen Group PLC
QuVa Pharma
ITC Compounding Pharmacy
Advanced Pharmacy
For more information about this report visit https://www.researchandmarkets.com/r/jdfekl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
